Everything below concerns Lipodystrophy. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-20. Where a claim depends on a specific study, the study is described rather than over-claimed.
Common analytical approaches include reversed-phase high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Peptide mapping after enzymatic digestion can verify the expected sequence. Immunoassays may be used to measure the compound or its downstream markers, but they can cross-react with related peptides and require careful validation. Impurity profiles typically include truncated sequences, oxidized methionine residues, and residual solvents from synthesis. Each method reports a different property, so no single assay establishes overall quality.
Storage claims vary across suppliers, and published stability data for specific formulations are limited. Extrapolating from related peptides is common but not a substitute for direct measurement. For research use, documentation such as a certificate of analysis is often requested to confirm identity and purity. What constitutes an acceptable purity threshold depends on the intended application. Open questions remain about how temperature excursions during shipping affect long-term peptide integrity. Independent verification by an end user is not routinely reported.
Lyophilized tesamorelin is generally stored refrigerated at 2 to 8 degrees Celsius, protected from light and moisture. Peptides in this class are often kept frozen at minus 20 degrees Celsius for longer periods. Reconstituted solutions are typically used within a defined window because hydrolysis and oxidation proceed faster in liquid form. Container material and headspace also influence how long a preparation retains its expected profile. Specific stability figures depend on concentration and buffer composition.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized powder | Requires reconstitution before use |
| Solubility | Soluble in water | Also dissolves in aqueous buffers |
| Storage, powder | 2 to 8 degrees Celsius | Protect from light and moisture |
| Storage, solution | Refrigerated, short term | Use promptly after reconstitution |
| Common assays | Reversed-phase HPLC and mass spectrometry | Purity and identity respectively |
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
研究用与临床用材料的标准并不相同。质量控制通常覆盖纯度、残留溶剂、反离子含量、微生物限度与内毒素水平，各项均有对应检测方法。随货文件应包含批号、检测项目、方法与结果，使数据可以追溯。核验时应关注纯度是否按主峰面积计算、杂质是否已定性、方法是否经过验证，这些信息决定结果能否被外部重复。
纯度与身份确认依赖色谱与质谱的组合。反相高效液相色谱在 214 nm 紫外检测下分离主峰与相关杂质，给出纯度百分比与保留时间；电喷雾或基质辅助激光解吸电离质谱提供分子量，用于确认 N 端修饰是否完整。序列层面可通过肽图或氨基酸分析验证。含量测定常用紫外吸收法或氮元素分析，不同方法之间需要做交叉校验。
冻干粉末一般在 -20°C 或更低温度、干燥避光条件下保存，可维持较长时间的稳定。复溶后稳定性明显下降，溶液中的肽链易发生水解、氧化与聚集，通常需冷藏并在短期内用完。反复冻融会加速聚集与降解，建议分装后单次使用。缓冲体系的 pH 与离子强度同样影响聚集速率，需要按具体实验条件验证。
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Paul Bottomley is an American, English and Australian medical physicist. He pioneered the development of magnetic resonance imaging (MRI) that lead to modern commercial clinical 1.5 tesla MRI scanners, along with methods for performing noninvasive localized magnetic resonance spectroscopy (MRS) and applying them to the study of energy supply in human heart disease. In 2022 he retired as Russell H. Morgan Professor of Radiology and Director of the Division of MR Research at Johns Hopkins University where he is currently Professor Emeritus. He has about 200 peer-reviewed journal articles, over 50 U.S patents in MRI, MRS, and MRI-safe implantable lead technologies. He was a Founder and past member of the Board of Directors of SurgiVision Inc, a 1998 Johns Hopkins University start-up company which became MRI Interventions Inc, and is currently known as ClearPoint Neuro Inc.
While other plants have δ15N values that range from 2 to 6‰, legumes have lower 14N/15N ratios (close to 0‰, i.e. atmospheric N2) because they can fix molecular nitrogen, rather than having to rely on soil nitrates and nitrites. Therefore, one potential explanation for lower δ15N values in human remains is an increased consumption of legumes or animals that eat them. 15N values increase with meat consumption, and decrease with legume consumption. The 14N/15N ratio could be used to gauge the contribution of meat and legumes to the diet.
=== Hospital acute care === Bridion (sugammadex) ($1.7 billion in 2024 revenues) is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium in general anaesthesia. Prevymis (letermovir) ($0.8 billion in 2024 revenues) is used for the prevention of cytomegalovirus infections. Dificid (fidaxomicin) ($0.3 billion in 2024 revenues) is a tiacumicin. Zerbaxa (ceftolozane/tazobactam ($0.3 billion in 2024 revenues) is an antibiotic used to treat urinary tract infections. Noxafil (posaconazole) ($0.2 billion in 2024 revenues) is a triazole antifungal.
With regard to adverse drug reactions, there is data from animal studies that "long-term administration of human growth hormone can increase the risk of diabetes, retention of fluids, joint and muscle pain, hypertension, cardiomyopathy, osteoporosis, irregular menstruation, impotence and elevated HDL cholesterol." A report from the United States House Committee on Oversight and Government Reform on steroid and growth hormone use found that the misguided use of HGH by professional athletes and entertainers was fuelling the industry peddling the drug to the general public for medically inappropriate uses.
== Human rights abuses == Various groups have claimed that SWAPO committed serious human rights abuses against suspected spies during the independence struggle. Since the early 21st century, they have pressed the government more strongly on this issue. Breaking the Wall of Silence (BWS) is one of the groups founded by people who were detained by SWAPO during the war and abused during interrogations. In 2004, BWS alleged that "In exile, hundreds of SWAPO dependants and members were detained, tortured and killed without trial." SWAPO denies serious infractions and claims anything that did happen was in the name of liberation. Because of a series of successful South African raids, the SWAPO leadership believed that spies existed in the movement. Hundreds of SWAPO cadres were imprisoned, tortured and interrogated.
Sources: en.wikipedia.org
== Publications == Maroon has published over 340 peer-reviewed scientific articles, some of which may be found in the United States National Library of Medicine's publication database; his H-index, a measure of scientific research impact, is 74 (as of June 2025). As of early 2026, his work has garnered more than 27,300 total citations. Currently, Maroon is working with Dr. Pravat K. Mandal and has proposed oxidative stress as the underlying pathogenesis of Alzheimer's disease and Parkinson's disease.
== History == The existence of tRNA was first hypothesized by Francis Crick as the "adaptor hypothesis" based on the assumption that there must exist an adapter molecule capable of mediating the translation of the RNA alphabet into the protein alphabet. Paul C Zamecnik, Mahlon Hoagland, and Mary Louise Stephenson discovered tRNA in 1958. Significant research on structure was conducted in the early 1960s by Alex Rich and Donald Caspar, two researchers in Boston, the Jacques Fresco group in Princeton University and a United Kingdom group at King's College London. In 1965, Robert W. Holley of Cornell University reported the primary structure and suggested three secondary structures. tRNA was first crystallized in Madison, Wisconsin, by Robert M. Bock. The cloverleaf structure was ascertained by several other studies in the following years and was finally confirmed using X-ray crystallography studies in 1974. Two independent groups, Kim Sung-Hou working under Alexander Rich and a British group headed by Aaron Klug, published the same crystallography findings within a year.
in [a black bear] chase there is much excitement, and occasionally a slight spice of danger, just enough to render it attractive; so it has always been eagerly followed. He wrote that black bears were difficult to hunt by stalking, due to their habitat preferences, though they were easy to trap. Roosevelt described how, in the southern states, planters regularly hunted bears on horseback with hounds. General Wade Hampton was known to have been present at 500 successful bear hunts, two-thirds of which he killed personally. He killed 30 or 40 bears with only a knife, which he would use to stab the bears between the shoulder blades while they were distracted by his hounds. Unless well trained, horses were often useless in bear hunts, as they often bolted when the bears stood their ground. In 1799, 192,000 American black bear skins were exported from Quebec. In 1822, 3,000 skins were exported from the Hudson's Bay Company. In 1992, untanned, fleshed and salted hides were sold for an average of $165. In Canada, black bears are considered as both a big game and furbearer species in all provinces, save for New Brunswick and the Northwest Territories, where they are only classed as a big game species. There are around 80,900 licensed bear hunters in Canada. Canadian black bear hunts take place in the fall and spring, and both male and female bears can be legally taken, though some provinces prohibit the hunting of females with cubs, or yearlings. Currently, 28 of the U.S. states have American black bear hunting seasons.
== Society and culture == Pentobarbital is the INN, AAN, BAN, and USAN, while pentobarbitone is a former AAN and BAN. One brand name for this drug is Nembutal, coined by John S. Lundy, who started using it in 1930, from the structural formula of the sodium salt—Na (sodium) + ethyl + methyl + butyl + al (common suffix for barbiturates). Nembutal is trademarked and manufactured by the Danish pharmaceutical company Lundbeck (now produced by Akorn Pharmaceuticals), which is the only injectable form of pentobarbital approved for sale in the United States. However, European Union restrictions on the export of drugs used to impose the death penalty constrained the availability of the drug in the United States and Canada. Attempts by drug smugglers to transport pentobarbital from Mexico to the United States have been reported since 2018. Ernest H. Volwiler and Donalee L. Tabern developed pentobarbital at Abbott Laboratories in 1930. Abbott discontinued its Nembutal brand of pentobarbital capsules in 1999, largely replaced by the benzodiazepine family of drugs. Abbott's Nembutal, known on the streets as "yellow jackets", was widely abused. They were available as 30, 50, and 100 mg capsules of yellow, white-orange, and yellow colors, respectively. In the 2025 mystery film Wake Up Dead Man, lethal doses of pentobarbital are used as a slow-acting poison in the murder of two separate characters.
Convulxin is a snake venom toxin found in a tropical rattlesnake known as Crotalus durissus terrificus. It belongs to the family of hemotoxins, which destroy red blood cells or, as is the case with convulxin, induce blood coagulation. It causes platelet activation in the blood, forming clots and buildup of pressure. Convulxin acts as an agonist to the GPVI receptor, the major signalling receptor for collagen. This can cause the blood stream to burst, or the heart or brain to lose blood, thus resulting in death. It is a tetramer C-type lectin with an oligomeric structure, made up of heterodimeric subunits.
Sources: en.wikipedia.org
Notably, about half of her graduate and post-graduate trainees in the past decade have identified as female. She has mentored a next generation of academic faculty in nanomedicine and bioengineering at institutions worldwide. Notable alumni from her lab include:
==== Steroids ==== The hypothalamus contains neurons that react strongly to steroids and glucocorticoids (the steroid hormones of the adrenal gland, released in response to ACTH). It also contains specialized glucose-sensitive neurons (in the arcuate nucleus and ventromedial hypothalamus), which are important for appetite. The preoptic area contains thermosensitive neurons; these are important for TRH secretion.
During World War I Hahn served with a Landwehr regiment on the Western Front, and with the chemical warfare unit headed by Fritz Haber on the Western, Eastern and Italian fronts, earning the Iron Cross (2nd Class) for his part in the First Battle of Ypres. After the war he became the head of the KWIC, while remaining in charge of his own department. Between 1934 and 1938, he worked with Strassmann and Meitner on the study of isotopes created by neutron bombardment of uranium and thorium, which led to the discovery of nuclear fission. He was an opponent of Nazism and the persecution of Jews by the Nazi Party that caused the removal of many of his colleagues, including Meitner, who was forced to flee Germany in 1938. Nonetheless, during World War II, he worked on the German nuclear weapons program, cataloguing the fission products of uranium. At the end of the war he was arrested by the Allied forces and detained in Farm Hall with nine other German scientists, from July 1945 to January 1946. Hahn served as the last president of the Kaiser Wilhelm Society for the Advancement of Science in 1946 and as the founding president of its successor, the Max Planck Society from 1948 to 1960. In 1959, he co-founded the Federation of German Scientists, a non-governmental organisation committed to the ideal of responsible science. As he worked to rebuild German science, he became one of the most influential and respected citizens of post-war West Germany.
canis is also unique from other Brucella species in that they demonstrate a distinctive phospholipid arrangement that differ greatly from other Gram-negative bacteria. Their envelope incorporates uncommon lipid species such as altered phosphatidylethanolamine and lipid A derivatives enriched with long-chain and branched fatty acids; features that reflect evolutionary adaptation to an intracellular lifecycle. Additionally, its phospholipid portion is mainly composed of cis-vaccenic cyclopropane with small amounts of lactobaccilic acid. This differs from other Brucella species, as they demonstrate the opposite composition, with lactobacillic acid making up the majority of the phospholipid fraction. Brucella is unusual in this composition because lactobacillic acid is typically within Gram-positive organisms but not common within Gram-negative organisms such as Brucella. These specific envelope features are discussed alongside the organisms hallmark intracellular cycle. After uptake, Brucella replicate within ER-derived Brucella containing vacuoles, a niche specific to replication and survival within B. canis.
3-Phosphoglyceric acid (3PG, 3-PGA, or PGA) is the conjugate acid of 3-phosphoglycerate or glycerate 3-phosphate (GP or G3P). This glycerate is a biochemically significant metabolic intermediate in both glycolysis and the Calvin-Benson cycle. The anion is often termed as PGA when referring to the Calvin-Benson cycle. In the Calvin-Benson cycle, 3-phosphoglycerate is typically the product of the spontaneous scission of an unstable 6-carbon intermediate formed upon CO2 fixation. Thus, two equivalents of 3-phosphoglycerate are produced for each molecule of CO2 that is fixed. In glycolysis, 3-phosphoglycerate is an intermediate following the dephosphorylation (reduction) of 1,3-bisphosphoglycerate.
Sources: en.wikipedia.org
Refrigeration between 2 and 8 degrees Celsius with protection from light is the common recommendation. Many laboratories choose frozen storage at minus 20 degrees Celsius when the material will not be used soon. Repeated temperature cycling is generally avoided.
Mass spectrometry gives the observed mass, which is compared against the value calculated from the sequence. Peptide mapping after digestion provides a second, sequence-level check. Chromatographic retention alone is not sufficient for identity.
Antibodies raised against one GHRH-related peptide may bind other members of the same family. That cross-reactivity inflates or distorts measured concentrations. Assay validation with defined standards is therefore necessary before results are interpreted.
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.